VANGUARD GROUP INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 292 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$1,323,465
+67.5%
102,277
+79.8%
0.00%
Q1 2024$790,077
-2.7%
56,8810.0%0.00%
Q4 2023$811,692
-7.8%
56,8810.0%0.00%
Q3 2023$879,949
-60.1%
56,881
-59.4%
0.00%
Q2 2023$2,203,092
-7.9%
140,235
-3.4%
0.00%
Q1 2023$2,392,715
-23.8%
145,189
-27.9%
0.00%
Q4 2022$3,141,980
-5.6%
201,409
-21.5%
0.00%
Q3 2022$3,327,000
-70.1%
256,504
-67.7%
0.00%
Q2 2022$11,138,000
-44.5%
793,277
-43.4%
0.00%
Q1 2022$20,070,000
-15.2%
1,401,552
-19.3%
0.00%
-100.0%
Q4 2021$23,674,000
-27.5%
1,736,931
-12.9%
0.00%0.0%
Q3 2021$32,655,000
-22.3%
1,993,608
-20.1%
0.00%0.0%
Q2 2021$42,010,000
-12.7%
2,496,142
-5.3%
0.00%0.0%
Q1 2021$48,117,000
-12.6%
2,635,127
-12.9%
0.00%
-50.0%
Q4 2020$55,051,000
-12.6%
3,024,768
-14.4%
0.00%0.0%
Q3 2020$63,004,000
-22.6%
3,531,592
-22.2%
0.00%
-33.3%
Q2 2020$81,368,000
-5.6%
4,538,071
-20.1%
0.00%
-25.0%
Q1 2020$86,180,000
-26.9%
5,677,186
-5.0%
0.00%0.0%
Q4 2019$117,930,000
+11.4%
5,977,204
-2.9%
0.00%0.0%
Q3 2019$105,846,000
-10.7%
6,153,843
-8.1%
0.00%0.0%
Q2 2019$118,521,000
-13.1%
6,696,1050.0%0.00%
-20.0%
Q1 2019$136,400,0006,696,1050.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 9,270,535$188,841,00039.13%
Sachem Head Capital 5,963,600$121,479,0007.38%
NINE MASTS CAPITAL Ltd 1,049,886$21,415,0006.68%
Paulson & Co. 26,489,422$539,590,0005.77%
Blackcrane Capital, LLC 189,549$3,861,0005.16%
Glenview Capital Management 26,112,660$531,915,0004.75%
Exane Asset Management 430,369$8,766,617,0004.26%
Velanne Asset Management Ltd 281,972$5,744,0003.97%
Bluefin Trading, LLC 1,204,702$24,540,0003.55%
Endurant Capital Management LP 437,436$8,911,0003.52%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders